One Case of Skin Rash and Severe Thrombocytopenia Induced by Oxcarbazepine Tablets

Abstract

CLC Number:

R994.11

GUO Hao-ning, WU Si-lin, ZHANG Li, HE Miao-quan. One Case of Skin Rash and Severe Thrombocytopenia Induced by Oxcarbazepine Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(6): 368-369.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2018/V15/I6/368

[1] Shankar B R.Quetiapine-induced leucopenia and thrombocytopenia[J]. Psychosomatics, 2007, 8(6): 530-531.
[2] 孙燕, 仵钊锋. 度洛西汀临床不良反应分析[J]. 河南大学学报(医学版), 2015,(2): 142-144.
[3] 王健, 马辛. 丙戊酸镁缓释片致血小板减少症1例[J]. 临床精神医学杂志, 2016, 26(3): 216.
[4] 汪作为, 陈银娣. 喹硫平所致血小板减少症1例[J]. 精神医学杂志, 2009, 22(5): 384.
[5] 李焕芬, 陈建华, 朱利芳. 奥卡西平片致血小板减少1例[J]. 中国药物警戒, 2015, 12(11): 700.
[6] 王丹. 诺华公司警告奥卡西平的严重皮肤反应[J]. 中国药物警戒, 2005, 2(4): 252.
[7] 杨华, 魏晶, 王嘉仡, 等. 药品不良反应/事件报告评价方法研究[J]. 中国药物警戒, 2009, 6(10): 581-584.
[8] 卫生部合理用药专家委员会. 中国医师药师临床用药指南[M]. 1版. 重庆: 重庆出版社, 2009: 1132-1133.
[9] Schmidt D, Elger C E.What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?[J]. Epilepsy Behavior, 2004, 5(5): 627-635.
[10] 仇锦春, 廖清船, 张永, 等. 奥卡西平致皮疹、血小板减少性紫癜1例[J]. 中国现代应用药学, 2011, 28(11): 1067-1068.
[11] He X, Kang S, Wang F, et al.Oxcarbazepine-related thrombocytopenic purpura[J]. Journal of Clinical Psychopharmacology, 2011, 31(1): 137-138.
[12] 方舒, 龚志成. 奥卡西平的不良反应[J]. 中国当代儿科杂志, 2015, 17(4): 414-419.
[13] 何学莲, 王芳琳, 吴革菲, 等. 奥卡西平诱发的Stevens-Johnson综合征的临床特点及基因表达[J]. 中华实用儿科临床杂志, 2011, 26(5): 360-362.
[14] Tutorcrespo M J, Hermida J, Tutor J C.Relation of blood platelet count during carbamazepine and oxcarbazepine treatment with daily dose, and serum concentrations of carbamazepine, carbama-zepine-10,11-epoxide, and 10-hydroxycarbazepine[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2007, 151(1): 91-94.
[15] Hurley J S, Roberts M, Solberg L I.Laboratory safety monitoring of chronic medications in ambulatory care settings[J]. J Gen Intern Med, 2005, 20(4): 331-333.
[16] Martinez W, Ingenito A, Blakeslee M, et al.Efficacy, safety, and tolerability of oxcarbazepine monotherapy[J]. Epilepsy Behavior, 2006, 9(3): 448-456.

One Case of Skin Rash and Severe Thrombocytopenia Induced by Oxcarbazepine Tablets

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850.
[2]	WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855.
[3]	XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862.
[4]	CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875.
[5]	CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882.
[6]	ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888.
[7]	SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
[8]	SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
[9]	YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
[10]	KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
[11]	LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
[12]	LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
[13]	ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
[14]	ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
[15]	CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.